Ledger.Open graph →
SEC Form D · Amendment · filed February 27, 2017

Citius Pharmaceuticals, Inc

Offering
$6.0M
Sold
$550K
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
CRANFORD, NJ
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (21)

Myron Holubiak · Cranford, NJExec · DirectorJ.P. R. Bourtin · Fredericksburg, TXDirectorRuben M. De La Fuente Jimenez · Boadilla Del Monte, Madrid, U3Exec · DirectorJesse C. Russell · Bend, ORDirectorLeonard Mazur · Cranford, NJExec · DirectorCarol Webb · Cranford, NJDirectorUna E. Ryan · SEATTLE, WADirectorWilliam Kane · Cranford, NJDirectorSuren Dutia · Cranford, NJDirectorDavid W. Grieger · SEATTLE, WADirectorSteven E. Pope · SEATTLE, WADirectorHoward Safir · Cranford, NJDirectorDick E. Henriques · SEATTLE, WADirectorSean Moghavem · Beverly Hills, CAExec · DirectorCharles E. Mcnerney · SEATTLE, WAExec · DirectorJames Lockhart · Lithia, FLDirectorQili Li · Annandale, VADirectorBennett M. Butters · SEATTLE, WADirectorEugene Holuka · Cranford, NJDirectorMichael Liang · Seattle, WADirectorClark W. Donnell · SEATTLE, WAExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗